A budget impact analysis of empagliflozin for heart failure patients with full spectrum of ejection fraction in South Korea

Back

HFA Premium Access

A budget impact analysis of empagliflozin for heart failure patients with full spectrum of ejection fraction in South Korea

Session: Chronic heart failure - pharmacotherapy 6

Topic: Pharmacotherapy

Speaker: Professor J. Youn (Seoul, KR)

Event: Heart Failure 2023

Congress Presentation

Add to my library

About the speaker

Professor Jong-Chan Youn

Seoul St. Mary's Hospital, The Catholic University of Korea, Seoul (Korea (Republic of))

0 follower

5 more presentations in this session

Total cholesterol decrease associates with higher mortality in chronic heart failure

Speaker: Doctor M. Rocha (Porto, PT)

Access

Abstract

Slides

Safety, pharmacokinetics, and pharmacodynamics of AZD3427, a functionally selective long acting relaxin mimetic agonist of the RXFP1 receptor

Speaker: Professor M. Ufnal (Gothenburg, SE)

Access

Abstract

Slides

Hypoalbuminemia increases the time to euvolemia in heart failure patients

Speaker: Doctor I. Fialho (Lisbon, PT)

Access

Abstract

Slides

Timing of statistical benefit of canagliflozin in patients with type 2 diabetes for cardiovascular and heart failure outcomes: insights from the CANVAS Program and CREDENCE trial

Speaker: Doctor A. Sharma (Montreal, CA)

Access

Abstract

Slides

Long-acting relaxin (LY3540378) demonstrates improved renal hemodynamics response in preclinical and clinical studies

Speaker: Doctor X. Wang (Indianapolis, US)

Access

Abstract

Slides

Access the full session

Chronic heart failure - pharmacotherapy 6

Speakers: Professor J. Youn, Doctor M. Rocha, Professor M. Ufnal, Doctor I. Fialho, Doctor A. Sharma...

Access

About the event

Heart Failure 2023

20 May - 23 May 2023

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources